Rocuronium Bromide (Mylan Institutional LLC)
Welcome to the PulseAid listing for the Rocuronium Bromide drug offered from Mylan Institutional LLC. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Institutional LLC |
NON-PROPRIETARY NAME: | rocuronium bromide |
SUBSTANCE NAME: | ROCURONIUM BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-09-29 |
END MARKETING DATE: | 0000-00-00 |
Rocuronium Bromide HUMAN PRESCRIPTION DRUG Details:
Item Description | Rocuronium Bromide from Mylan Institutional LLC |
LABELER NAME: | Mylan Institutional LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2014-09-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67457-573_8c053988-305d-4cb9-ad10-604af0daa318 |
PRODUCT NDC: | 67457-573 |
APPLICATION NUMBER: | ANDA079199 |
Other ROCURONIUM BROMIDE Pharmaceutical Manufacturers / Labelers: